Laboratory Corporation of America Holdings (NYSE:LH)
203.07 USD
+1.590 0.789%Previous Close (in USD) | 201.48 |
---|---|
Change | +1.590 0.789% |
52 W H/L (in USD) | 225.270/178.372 |
EBITDA (in USD) | 2127.8M |
PE Ratio | 23.09 |
Volume | 684196 |
Diluted Eps TTM | 9.70 |
Total Assets (in USD) | 20155.1M |
---|---|
Total Liabilities (in USD) | 10058.5M |
Revenue TTM (in USD) | 15070.9M |
Cash (in USD) | 430M |
Market Cap (in USD) | 19,019.299 M |
Revenue Per Share TTM | 171.066 |
Gross Profit TTM (in USD) | 4385.1M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Laboratory Corporation of America Holdings
Employees: 60000
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. Adam H. Schechter | Pres, CEO & Chairman | 1965 |
2. | Mr. Glenn A. Eisenberg | CFO & Exec. VP | 1961 |
3. | Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH | Exec. VP, Pres of Diagnostics & Chief Medical Officer | 1974 |
4. | Mr. Mark S. Schroeder | Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain | 1961 |
5. | Dr. Paul R. Kirchgraber M.D. | Exec. VP & CEO of Covance Drug Devel. | 1962 |
6. | Dr. Michelle Abelson Ph.D. | Laboratory Director of Operations | NA |
7. | Mr. Peter J. Wilkinson | Sr. VP & Chief Accounting Officer | 1972 |
8. | Mr. Lance V. Berberian | Exec. VP and Chief Information & Technology Officer | 1963 |
9. | Dr. Marcia T. Eisenberg Ph.D. | Chief Scientific Officer & Sr. VP | 1960 |
10. | Chas Cook | VP of Investor Relations | NA |
Peers
Sector: Healthcare
Industry: Diagnostics & Research
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
TMO
Thermo Fisher Scientific Inc |
+3.600 0.661% | 549.15 | 34.710 | 23.866 | 4.622 | 4.428 | 5.293 | 20.886 |
DHR
Danaher Corporation |
+0.570 0.242% | 235.96 | 29.090 | 28.011 | 5.669 | 3.198 | 5.999 | 19.094 |
IDXX
IDEXX Laboratories Inc |
+3.220 0.676% | 479.475 | 55.570 | 53.763 | 12.499 | 34.556 | 12.721 | 38.211 |
IQV
IQVIA Holdings Inc |
+3.250 1.425% | 230.36 | 37.820 | 19.685 | 2.764 | 7.195 | 3.607 | 17.031 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | 1582.6M | 3126.6M | 2219.1M | 1104.9M | 1268.3M |
Minority Interest | -1.5M | -2.2M | 20.7M | 20.1M | 0.2M |
Net Income | 1279.1M | 2377.3M | 1556.1M | 823.8M | 883.7M |
Selling General Administrative | 1996.6M | 1952.1M | 1729M | 1624.5M | 1570.9M |
Gross Profit | 4385.1M | 5624.3M | 4952.8M | 3252.5M | 3176.4M |
Reconciled Depreciation | 633.9M | 745.1M | 624.7M | 577.2M | 552.1M |
Ebit | 1773.9M | 3259.5M | 2445.4M | 1330.2M | 1553.1M |
Ebitda | 2743.2M | 4116.7M | 3543.6M | 1968.6M | 2105.2M |
Depreciation And Amortization | 969.3M | 857.2M | 1098.2M | 638.4M | 552.1M |
Operating Income | 1773.9M | 3259.5M | 2445.4M | 1330.2M | 1325.7M |
Other Operating Expenses | 12747.6M | 12818.3M | 11030.4M | 10170M | 9959.6M |
Interest Expense | 180.3M | 212.1M | 207.4M | 240.7M | 244.2M |
Tax Provision | 302M | 747.1M | 662.1M | 280M | 384.4M |
Interest Income | 166M | 175.4M | 194.2M | 212.3M | 225.1M |
Net Interest Income | -180.3M | -212.1M | -207.4M | -240.7M | -244.2M |
Income Tax Expense | 302M | 747.1M | 662.1M | 280M | 384.4M |
Total Revenue | 14876.8M | 16120.9M | 13978.5M | 11554.8M | 11333.4M |
Total Operating Expenses | 2255.9M | 2321.7M | 2004.7M | 1867.7M | 1802.6M |
Cost Of Revenue | 10491.7M | 10496.6M | 9025.7M | 8302.3M | 8157M |
Total Other Income Expense Net | -191.3M | -132.9M | -226.3M | -225.3M | 138.7M |
Net Income From Continuing Ops | 1280.6M | 2379.5M | -0.9M | 824.9M | 883.9M |
Net Income Applicable To Common Shares | 1279.1M | 2377.3M | -0.9M | 823.8M | 883.7M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 20155.1M | 20385.4M | 20071.7M | 18021.4M | 16185.3M |
Intangible Assets | 3946.9M | 3735.5M | 3961.1M | 4034.5M | 3911.1M |
Other Current Assets | 707M | 478.1M | 364.8M | 373.7M | 309M |
Total Liab | 10058.5M | 10112.5M | 10712M | 10454.4M | 9213.9M |
Total Stockholder Equity | 10096.6M | 10272.9M | 9359.7M | 7567M | 6971.4M |
Other Current Liab | 1068.8M | 1404.1M | 1357.7M | 942.4M | 870M |
Common Stock | 8.1M | 8.5M | 9M | 9M | 11.7M |
Capital Stock | 8.1M | 8.5M | 9M | 9M | 11.7M |
Retained Earnings | 10581.7M | 10456.4M | 9402.3M | 7903.6M | 7079.8M |
Good Will | 8121M | 7958.9M | 7751.5M | 7865M | 7360.3M |
Other Assets | 440.3M | 484.2M | 350.9M | 356.5M | 277.7M |
Cash | 430M | 1472.7M | 1320.8M | 337.5M | 426.8M |
Cash And Equivalents | 430M | 1472.7M | 1320.8M | 337.5M | 426.8M |
Total Current Liabilities | 3078.5M | 2782.9M | 3078.5M | 2646.8M | 1878.9M |
Current Deferred Revenue | 582.1M | 558.5M | 506.5M | 451M | 356.4M |
Net Debt | 5864.9M | 4869.9M | 5435.6M | 6745.1M | 5633M |
Short Term Debt | 492.8M | 199M | 575.4M | 621.1M | 17.9M |
Short Long Term Debt | 301.3M | 1.5M | 376.7M | 415.2M | 10M |
Short Long Term Debt Total | 6294.9M | 6342.6M | 6756.4M | 7082.6M | 6059.8M |
Other Stockholder Equity | -493.2M | -192M | 110.3M | 26.8M | 343M |
Property Plant Equipment | 2956.2M | 2815.4M | 2809.3M | 2724.3M | 1784.7M |
Total Current Assets | 4625M | 5330.5M | 5125.4M | 2981.2M | 2835.4M |
Long Term Investments | 65.7M | 60.9M | 73.5M | 84.9M | 60.5M |
Short Term Investments | - | - | 73M | 9.1M | - |
Net Receivables | 3017.4M | 2978.3M | 3016.6M | 2025.3M | 1862.3M |
Long Term Debt | 5038.8M | 5416.5M | 5419M | 5789.8M | 6041.9M |
Inventory | 470.6M | 401.4M | 423.2M | 244.7M | 237.3M |
Accounts Payable | 934.8M | 621.3M | 638.9M | 632.3M | 634.6M |
Accumulated Other Comprehensive Income | -493.2M | -192M | -161.9M | -372.4M | -463.1M |
Non Currrent Assets Other | 432.7M | 462.6M | 410M | 435.4M | 231.6M |
Non Current Assets Total | 15530.1M | 15054.9M | 14946.3M | 15040.2M | 13349.9M |
Capital Lease Obligations | 954.8M | 924.6M | 960.7M | 902.6M | 58.9M |
Long Term Debt Total | 5122.4M | 5501.1M | 5503.4M | 5880.9M | 6041.9M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -1652.2M | -14.6M | -643.2M | -1283.1M | -4M |
Total Cashflows From Investing Activities | -1652.2M | -884.6M | -643.2M | -1283.1M | 206.7M |
Total Cash From Financing Activities | -1322.2M | -2065.8M | -517.4M | -252.7M | -1389.9M |
Net Income | 1280.6M | 2379.5M | 1557M | 824.9M | 883.9M |
Change In Cash | -1042.7M | 151.9M | 983.3M | -89.3M | 110.2M |
Begin Period Cash Flow | 1472.7M | 1320.8M | 337.5M | 426.8M | 316.6M |
End Period Cash Flow | 430M | 1472.7M | 1320.8M | 337.5M | 426.8M |
Total Cash From Operating Activities | 1955.9M | 3109.6M | 2135.3M | 1444.7M | 1305.4M |
Depreciation | 633.9M | 745.1M | 624.7M | 577.2M | 552.1M |
Other Cashflows From Investing Activities | -1170.3M | -424.2M | 3.1M | 1.7M | 590.5M |
Dividends Paid | -195.2M | -1000M | -151.7M | -2395M | 467.2M |
Change To Inventory | -45.5M | 2.8M | -196.6M | -21.9M | -18.9M |
Sale Purchase Of Stock | -1100M | -1668.5M | -100M | -450M | -700M |
Other Cashflows From Financing Activities | 709.8M | 1926M | 242.3M | 4712.5M | 880M |
Capital Expenditures | 481.9M | 460.4M | 381.7M | 400.2M | 379.8M |
Change In Working Capital | -603.4M | -263.7M | -856.9M | -294.4M | -70.3M |
Other Non Cash Items | 482.4M | 170.9M | 745.8M | 200.8M | -174.1M |
Free Cash Flow | 1474M | 2649.2M | 1753.6M | 1044.5M | 925.6M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Vanguard Total Stock Mkt Idx Inv | 4 months ago | 2771430 |
2. | Vanguard Institutional 500 Index Trust | 4 months ago | 2158896 |
3. | Vanguard Mid Cap Index Institutional | 4 months ago | 2014094 |
4. | BlackRock Equity Dividend Instl | 4 months ago | 1500660 |
5. | Vanguard Health Care Inv | 6 months ago | 1485818 |
6. | Diamond Hill Large Cap Equity | 4 months ago | 1088976 |
7. | Fidelity® 500 Index | 5 months ago | 1025869 |
8. | SPDR® S&P 500 ETF Trust | 4 months ago | 1006974 |
9. | iShares Core S&P 500 ETF | 4 months ago | 873247 |
10. | Allspring Special Mid Cap Value Inst | 4 months ago | 766400 |
11. | Vanguard Value Index Inv | 4 months ago | 758660 |
12. | Vanguard Mid-Cap Value ETF | 4 months ago | 713162 |
13. | Health Care Select Sector SPDR® ETF | 4 months ago | 685031 |
14. | Diamond Hill Large Cap Inv | 4 months ago | 659918 |
15. | Allspring Special US Mid Cap Value Eq | 6 months ago | 600300 |
16. | Vanguard Institutional Index I | 4 months ago | 590937 |
17. | DFA US Large Cap Value I | 5 months ago | 557767 |
18. | JPMorgan Mid Cap Value L | 5 months ago | 526399 |
19. | JPM US Mid Cap Value-Composite | 6 months ago | 526399 |
20. | JPM US Mid Cap Value-MA | 6 months ago | 526399 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | BlackRock Inc | 6 months ago | 11875219 |
2. | Vanguard Group Inc | 6 months ago | 10192449 |
3. | State Street Corporation | 6 months ago | 3826543 |
4. | Wellington Management Company LLP | 6 months ago | 2487106 |
5. | Morgan Stanley - Brokerage Accounts | 6 months ago | 2219291 |
6. | Lazard Asset Management LLC | 6 months ago | 2212497 |
7. | Geode Capital Management, LLC | 6 months ago | 1918727 |
8. | Bank of America Corp | 6 months ago | 1492395 |
9. | Dimensional Fund Advisors, Inc. | 6 months ago | 1454978 |
10. | JPMorgan Chase & Co | 6 months ago | 1435709 |
11. | AllianceBernstein L.P. | 6 months ago | 1302342 |
12. | Diamond Hill Capital Management Inc | 6 months ago | 1280884 |
13. | UBS Asset Mgmt Americas Inc | 6 months ago | 1190479 |
14. | Northern Trust Corp | 6 months ago | 1129759 |
15. | FMR Inc | 6 months ago | 1065791 |
16. | Nuveen Asset Management, LLC | 6 months ago | 901920 |
17. | Veritas Investment Partners (UK) Ltd. | 6 months ago | 860672 |
18. | American Century Companies Inc | 6 months ago | 847753 |
19. | Allspring Global Investments Holdings, LLC | 6 months ago | 806975 |
20. | Thrivent Financial For Lutherans | 6 months ago | 778341 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).